The company is repurposing a currently-approved drug (undisclosed) as a topical serum to reverse grey hair by increasing stem cell resilience and restoring the ability to differentiate into melanocytes to color hair follicles. The presentation includes the planned timeline for trials and fundraising. Dr. Irit Rappley holds a PhD in neuroscience and worked for Bristol Myers Squibb. submitted by /u/lunchboxultimate01 [link] [comments]